Metabolites were quantified by nuclear magnetic resonance spectroscopy from fasting serum samples.

Brain metabolite concentrations were determined in vivo by proton magnetic resonance spectroscopy.

Structural determinations were carried out by chemical analysis and nuclear magnetic resonance spectroscopy.

Tumor energy metabolism was investigated in vivo by 31P nuclear magnetic resonance spectroscopy.

Frequent regional node involvement facilitates surface coil investigation with phosphorus-31 magnetic resonance spectroscopy.

Calf-muscle mitochondrial activity was measured with exercise-stimulated 31 P- magnetic resonance spectroscopy.

Body composition of mice was analysed via nuclear magnetic resonance spectroscopy and microcomputed tomography.

Hepatic glycogen concentrations were determined noninvasively using in vivo 13C nuclear magnetic resonance spectroscopy.

Lipoprotein particle numbers were determined by nuclear magnetic resonance spectroscopy.

The structure of silver cyanide has been investigated by solid-state multinuclear magnetic resonance spectroscopy.

Myocardial high-energy phosphates were examined by 31P magnetic resonance spectroscopy.

Liver fat was determined by 1H- magnetic resonance spectroscopy and glucose control by an OGTT.

Liver fat, VAT, and subcutaneous fat were determined by magnetic resonance spectroscopy and imaging.

Hepatic glycogen was assessed by natural abundance 13C nuclear magnetic resonance spectroscopy (MRS).

Metabolome profiles were obtained using nuclear magnetic resonance spectroscopy and analyzed in an untargeted manner.

Serum metabolites were measured by nuclear magnetic resonance spectroscopy.